Joerg H W Distler

TNF-induced structural joint damage is mediated by IL-1

Jochen Zwerina, Kurt Redlich, Karin Polzer et al. · Proceedings of the National Academy of Sciences · 2007 · 298 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

Pia Moinzadeh, Elisabeth Aberer, K Ahmadi-Simab et al. · Annals of the Rheumatic Diseases · 2014 · 103 citations · Full text

Medicine, Immunology, Autoimmunity +16

A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses

Jun Wei, Hongyan Zhu, Kazuhiro Komura et al. · Annals of the Rheumatic Diseases · 2013 · 75 citations

Medicine, Pathobiology, Pharmacology +14

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients

Pia Moinzadeh, Gabriela Riemekasten, Elise Siegert et al. · The Journal of Rheumatology · 2015 · 53 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique.

Joerg H W Distler, Suzana Jordan, Juan José Alegre Sancho et al. · PubMed · 2011 · 49 citations · Full text

Medicine, Immunology, Pharmacotherapy +13